Circulating levels of KL-6 in acute respiratory distress syndrome sepsis or traumatic brain injury in critically ill children

Pediatric Pulmonology

Volumn 41, Issue 8, 2006, Pages 790-795

  Briassoulis, George ^a,b   Mavrikiou, Maria ^b   Margeli, Alexandra ^b   Lazaropoulou, Christina ^b   Natsi, Labrini ^b   Papassotiriou, Ioannis ^b   Hatzis, Tasos ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Acute respiratory distress syndrome; Critically ill children; KL 6; Sepsis; Traumatic brain injury

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN; KL 6 PROTEIN; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; ANALYSIS OF VARIANCE; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEMOGRAPHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; STATISTICAL ANALYSIS; TRAUMATIC BRAIN INJURY;

ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BRAIN INJURIES; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LENGTH OF STAY; LINEAR MODELS; MALE; MUCIN-1; MUCINS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 33746613267     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20465     Document Type: Article

References (33)

1. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997;17:501-507.
2. Hilkens J, Ligtenberg MJ, Vos HL, Litvinov SV. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 1992;17:359-363.
3. Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 1998;158:1294-1298.
4. Kuwano K, Maeyama T, Inoshima I, Ninomiya K, Hagimoto N, Yoshimi M, Fujita M, Nakamura N, Shirakawa K, Hara N. Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases. Respirology 2002;7:15-21.
5. Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 1997;156:109-115.
6. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, Hiwada K. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:637-642.
7. Kohno N, Kyoizumi S, Awaya Y Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989;96: 68-73.
8. Kobayashi J, Kitamura S. KL-6. A serum marker for interstitial pneumonia. Chest 1995;108:311-315.
9. Kobayashi J, Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 1996;109:1276-1282.
10. Hamada H, Kohno N, Akiyama M, Hiwada K. Monitoring of serum KL-6 antigen in a patient with radiation pneumonia. Chest 1992;101:858-860.
11. Inoue Y, Nakata K, Arai T, Tazawa R, Hamano E, Nukiwa T, Kudo K, Keicho N, Hizawa N, Yamaguchi E, Eda R, Oishi K, Maeda Y, Koreeda Y, Kodo N, Sakatani M. Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. Respirology 2006;11:S55-S60.
12. Ohshimo S, Yokoyama A, Hattori N, Ishikawa N, Hirasawa Y, Kohno N. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts. Biochem Biophys Res Commun 2005;338:1845-1852.
13. Bernard G, Artigas A, Brigham K, Carlet J, Falke K, Judson L, Lamy M, Legal J, Morris A, Sprucg R. The American-European Consensus Conference on ARDS Definitions, Mechanisms, Relevant Outcomes, and Clinical Trial Coordination. Am J Respir Crit Care Med 1994;149:818-824.
14. Agouridakis P, Kyriakou D, Alexandrakis MG, Prekates A, Perisinakis K, Karkavitsas N, Bouros D. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res 2002;3:25-34.
15. Sato H, Callister ME, Mumby S, Quinlan GJ, Welsh KI, duBois RM, Evans TW. KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur Respir J 2004;23: 142-145.
16. Ishizaka A, Matsuda T, Albertine KH, Koh H, Tasaka S, Hasegawa N, Kohno N, Kotani T, Morisaki H, Takeda J, Nakamura M, Fang X, Martin TR, Matthay MA, Hashimoto S. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in the acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004;286:L1088-L1094.
17. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K, Acute Respiratory Distress Syndrome Network. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003;58:983-988.
18. Curley MA, Hibberd PL, Fineman LD, Wypij D, Shih MC, Thompson JE, Grant MJ, Barr FE, Cvijanovich NZ, Sorce L, Luckett PM, Matthay MA, Arnold JH. Effect of prone positioning on clinical outcomes in children with acute lung injury: A randomized controlled trial. JAMA 2005;294:229-237.
19. Thammasitboon S, Thammasitboon S. A critical appraisal of a systematic review: Sokol J, Jacob SE, Bohn D: Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev 2003;(1):CD002787.
20. Pediatr Crit Care Med 2005;6:340-343.
21. Flori HR, Ware LB, Glidden D, Matthay MA. Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med 2003;4: 315-321.
22. Bone R, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knous WA, Schein RM, Sibbald WJ. The ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20: 864-874.
23. Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988;16:1110-1116.
24. Keene AR, Cullen DJ. Therapeutic Intervention Scoring System: Update 1983. Crit Care Med 1983;11:1-3.
25. Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP, NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005;33:1-6.
26. Kashiwabara K. Characteristics and disease activity of early interstitial lung disease in subjects with true parenchymal abnormalities in the posterior subpleural aspect of the lung. Chest 2006;129:402-406.
27. Selman M, Pardo A. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2003;29:S93-S97.
28. Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, Hirasawa Y, Hiwada K. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1680-1684.
29. Zhao X, Dib M, Andersson E, Shi C, Widegren B, Wang X, Andersson R. Alterations of adhesion molecule expression and inflammatory mediators in acute lung injury induced by septic and non-septic challenges. Lung 2005;183:87-100.
30. Hager DN, Krishnan JA, Hayden DL, Brower RG. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005;172: 1241-1245.
31. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT, National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351: 327-336.
32. Flori HR, Glidden DV, Rutherford GW, Matthay MA. Pediatric acute lung injury: Prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 2005;171:995-1001.
33. Ashida T, Higashishiba M, Sumimoto Y, Sano T, Miyazato H, Shimada T, Miyatake J, Kawanishi K, Tatsumi Y, Kanamaru A. Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation. Int J Hematol 2001; 74:464-468.